References
- 1. Depuydt PO, Kress P, Salluh JIF. The ten “diseases” that are not true diseases. Intensive Care Med. 2016; 42:411-4.
- 2. Singer M, Deutchman CS, Seymour CW, Shankar-Hari M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315: 801-10.
- 3. Gattinoni L, Ranieri VM, Pesenti I. Sepsis: needs for defining severity. Intensive Care Med. 2015. 41: 551-2.
- 4. Shankar-Hari M, Bertolini G, Brunkhorst FM, et al. Judging quality of current septic shock definitions and criteria. Critical Care. 2015;19:445.
- 5. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013: 840-51.
- 6. Angus DC, Barnato AE, Bell D, Bellomo R, Choong C-R, Coats TJ et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the Arise, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41:1549-60.
- 7. *** The ProCESS/ARISE/ProMISe Methodology Writing Committee. Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med. 2013;39:1760-75.
- 8. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007;335:879-83.
- 9. Angus DC, Seymour CW, Coopersmith CM, et al. A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria. Crit Care Med. 2016;44:e113-e121.
- 10. Seymour CW, Coopersmith CM, Deutchmann CS, et al. Application of a framework to Assess the Usefulness of Alternative Sepsis Criteria. Crit Care Med. 2016;44:e122-e130.
- 11. Edward A. Continuing evolution but with much still to be done. JAMA. 2016;315:757-9.
- 12. Simpson QS. New Sepsis Criteria: A Change We Should Not Make. Chest. 2016. [Epub ahead of print] doi: 10.1016/j.chest.02.653
- 13. Zhang X, Liu D, Liu Y-N, Wang R, Xie L-X. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Critical Care. 2015;19: 323.
- 14. Rivers EP, Jaehne AK, Nguyer HB, et al. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: Not a time to give up, but to give it rearlier. Shock. 2013;39:127-37.
- 15. Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19:251.
- 16. www.sccm.org/sepsis redefined
- 17. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med. 2015; 372:1301-11.
- 18. www.sccmresponds to sepsis-3
- 19. Wang H, Donnelly JP, Griffin R, et al. Derivation of Novel Risk prediction scores for community-acquired sepsis and severe sepsis. Crit Care Med. 2016; [Epub ahead of print] doi: 10.1097/CCM.0000000000001666.
- 20. Albrich WC, Harbarth S. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med. 2015;41:1739-51.
- 21. Georgescu A-M, Szederjesi J, Copotoiu S-M, Azamfirei L. Predicting scores correlations in patients with septic shock-a cohort study. Rom J Anaesth Int Care. 2014;21:95-8.
- 22. http://cytosorb-therapy.com